Craig E. Eckfeldt, Ph.D.
Affiliations: | 2005 | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Cell BiologyGoogle:
"Craig Eckfeldt"Parents
Sign in to add mentor| Catherine M. Verfaillie | grad student | 2005 | UMN | |
| (Discovery and functional analysis of novel determinants of hematopoietic stem and progenitor cell function.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Felices M, Lenvik TR, Kodal B, et al. (2020) Potent Cytolytic Activity and Specific IL15 Delivery in a 2nd Generation Trispecific Killer Engager. Cancer Immunology Research |
| Yun HD, Schirm DK, Felices M, et al. (2019) Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia. Blood Advances. 3: 2448-2452 |
| Cong H, Zhao X, Castle BT, et al. (2018) An indole-chalcone inhibits multidrug-resistant cancer cell growth by targeting microtubules. Molecular Pharmaceutics |
| Yun HD, Schirm D, Felices M, et al. (2018) Cyclin-Dependent Kinases (CDK) Signaling Blockade Potentiates NK Cell Mediated Cytotoxicity Against Acute Myelogenous Leukemia Blood. 132: 4538-4538 |
| Pomeroy EJ, Eckfeldt CE. (2017) Targeting Ras signaling in AML: RALB is a small GTPase with big potential. Small Gtpases. 1-6 |
| Pomeroy EJ, Lee LA, Lee RD, et al. (2016) Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia. Oncogene |
| Eckfeldt CE, Pomeroy EJ, Lee RD, et al. (2016) RALB provides critical survival signals downstream of Ras in acute myeloid leukemia. Oncotarget |
| Sachs Z, Been RA, DeCoursin KJ, et al. (2016) Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency. Haematologica |
| Eckfeldt CE, Lee RD, Pomeroy EJ, et al. (2015) Abstract B01: Mechanisms of treatment resistance following Ras targeted therapy in acute myeloid leukemia. Clinical Cancer Research. 21 |
| Eckfeldt CE, Pomeroy EJ, Lee RD, et al. (2014) Ras Effector Pathways Differentially Support Proliferation and Survival of Acute Myeloid Leukemia Blood. 124: 3755-3755 |